Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


BioCryst Says FDA Approved Supplemental New Drug Application For RAPIVAB


RTTNews | Feb 3, 2021 07:21AM EST

07:20 Wednesday, February 3, 2021 (RTTNews.com) - BioCryst Says FDA Approved Supplemental New Drug Application For RAPIVAB

For comments and feedback: contact editorial@rttnews.com

https://www.rttnews.comCopyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC